Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Up 51.1% in August

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) saw a large growth in short interest in August. As of August 14th, there was short interest totaling 82,653 shares, a growth of 51.1% from the July 30th total of 54,710 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average trading volume of 2,525,183 shares, the days-to-cover ratio is presently 0.0 days.

Advanced Medical Isotope Trading Up 0.2%

OTCMKTS RDGL opened at $0.05 on Wednesday. Advanced Medical Isotope has a 12 month low of $0.05 and a 12 month high of $0.12. The stock has a market cap of $25.34 million, a price-to-earnings ratio of -5.13 and a beta of -0.72. The company’s 50 day moving average is $0.06 and its two-hundred day moving average is $0.07.

About Advanced Medical Isotope

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.